Biochemistry conferences

Academic and industrial drug-discovery researchers will compare approaches that connect molecular mechanisms with development candidates. The programme examines targeted protein degradation, three-dimensional discovery strategies, oral coronavirus antivirals and fragment-derived IL17A inhibitors. Further talks address screening unpurified reaction mixtures, regulating innate immune cells, optimizing QPCT/L and PolQ inhibitors with computational and experimental expertise, measuring protein-interaction selectivity and designing covalent inhibitors. Programme participants include Angela Russell (University of Oxford); Anna Barnard (Imperial College, London); Mike Waring (University of Newcastle); James Johnson (UCB); Jens Willwacher (Boehringer Ingelheim); Ageo Miccoli (Sygnature). SCI’s Fine Chemicals Group hosts this in-person meeting at SCI, 14/15 Belgrave Square, London SW1X 8PS. On 8 October 2026, registration starts at 09:20, opening remarks at 09:50 and scientific talks at 09:55; closing remarks are at 17:05, followed by a 17:15 reception. Times are Europe/London, BST (UTC+01:00). Registration closes on 5 October. Current fees are £135 for SCI members, £170 for non-members, £70 for student members and £81 for unemployed members; discounted eligibility is checked by SCI. Use SCI’s Register Now link to sign in or continue with event registration.

This EMBO Workshop connects organelle contact sites and cytoskeletal interactions with metabolism, signalling, and trafficking, and examines their relevance to neurodegeneration, cancer, and other diseases.

This EMBO Workshop examines how protein synthesis, folding, trafficking, and degradation shape health across the lifespan, connecting fundamental proteostasis mechanisms with ageing and degenerative disease.

One of the American Chemical Society's twice-yearly ACS Meetings & Expositions, held March 21-25, 2027 in New Orleans, LA, featuring presentations across the chemistry divisions and an exposition.